Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder
- 14 March 2014
- journal article
- research article
- Published by Elsevier BV in Human Pathology
- Vol. 45 (7), 1473-1482
- https://doi.org/10.1016/j.humpath.2014.02.024
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Diagnostic utility of p63/P501S double sequential immunohistochemical staining in differentiating urothelial carcinoma from prostate carcinomaDiagnostic Pathology, 2011
- Inverse p16 and p63 Expression in Small Cell Carcinoma and High-Grade Urothelial Cell Carcinoma of the Urinary BladderInternational Journal of Surgical Pathology, 2010
- Immunohistochemical Panel to Identify the Primary Site of Invasive Micropapillary CarcinomaThe American Journal of Surgical Pathology, 2009
- Expression of the Urothelial Differentiation Markers GATA3 and Placental S100 (S100P) in Female Genital Tract Transitional Cell ProliferationsThe American Journal of Surgical Pathology, 2009
- Persistent uroplakin expression in advanced urothelial carcinomas: implications in urothelial tumor progression and clinical outcomeHuman Pathology, 2007
- Urothelial carcinoma (clear cell variant) diagnosed with useful immunohistochemistry stainInternational Journal of Urology, 2006
- Invasive micropapillary carcinoma of the urinary bladder: An immunohistochemical study of neoplastic and stromal cellsInternational Journal of Urology, 2006
- Prostate-Specific Antigen, High-Molecular-Weight Cytokeratin (Clone 34βE12), and/or p63American Journal of Clinical Pathology, 2006
- Alternative epithelial markers in sarcomatoid carcinomas of the head and neck, lung, and bladder—p63, MOC-31, and TTF-1Laboratory Investigation, 2005
- Cytokeratin 14 as a marker of squamous differentiation in transitional cell carcinomas.Journal of Clinical Pathology, 1997